{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:55:22Z","timestamp":1772801722801,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.taap.2010.11.007","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T09:20:34Z","timestamp":1289985634000},"page":"8-15","source":"Crossref","is-referenced-by-count":23,"title":["FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells"],"prefix":"10.1016","volume":"251","author":[{"given":"Liang","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2010.11.007_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jnci\/90.5.370","article-title":"Synergistic anticancer effects of ganciclovir\/thymidine kinase and 5-fluorocytosine\/cytosine deaminase gene therapies","volume":"90","author":"Aghi","year":"1998","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.taap.2010.11.007_bb0010","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1158\/0008-5472.CAN-05-0921","article-title":"Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck","volume":"65","author":"Amornphimoltham","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2010.11.007_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/0008-5472.CAN-07-1756","article-title":"A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer","volume":"68","author":"Amornphimoltham","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2010.11.007_bb0020","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/cncr.24431","article-title":"Synergistic effect of rapamycin and cisplatin in endometrial cancer cells","volume":"115","author":"Bae-Jump","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2010.11.007_bb0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.taap.2010.11.007_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.taap.2010.11.007_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tcb.2008.07.004","article-title":"Unravelling the tumor-suppressive functions of FOXO proteins","volume":"18","author":"Dansen","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.taap.2010.11.007_bb0040","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1158\/1535-7163.MCT-08-0398","article-title":"FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells","volume":"7","author":"de Mattos","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2010.11.007_bb0045","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1","volume":"10","author":"Dijkers","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.taap.2010.11.007_bb0050","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1128\/MCB.20.24.9138-9148.2000","article-title":"Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1)","volume":"20","author":"Dijkers","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2010.11.007_bb0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jnci\/84.7.528","article-title":"Excision assay for initial evaluation of antitumor drug activity in mice bearing human tumor xenografts","volume":"84","author":"Dykes","year":"1992","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.taap.2010.11.007_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.taap.2010.11.007_bb0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2010.11.007_bb0070","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijom.2008.05.017","article-title":"Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2","volume":"37","author":"Fang","year":"2008","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.taap.2010.11.007_bb0075","doi-asserted-by":"crossref","unstructured":"Fang, L., Wang, H., Zhou, L., Yu, D., in press. Akt\u2013FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy. Oral Oncol., doi:10.1016\/j.oraloncology.2010.10.010.","DOI":"10.1016\/j.oraloncology.2010.10.010"},{"key":"10.1016\/j.taap.2010.11.007_bb0080","doi-asserted-by":"crossref","first-page":"397-U392","DOI":"10.1038\/ncb1847","article-title":"Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APC\u2013Cdh1-mediated Skp2 destruction","volume":"11","author":"Gao","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2010.11.007_bb0085","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4161\/cbt.5.7.2911","article-title":"Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells","volume":"5","author":"Gomez-Gutierrez","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.taap.2010.11.007_bb0090","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/cncr.23317","article-title":"Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer","volume":"112","author":"Hershko","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2010.11.007_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2009.09.015","article-title":"mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude mice","volume":"290","author":"Hou","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2010.11.007_bb0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.0406789102","article-title":"Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation","volume":"102","author":"Huang","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.taap.2010.11.007_bb0105","doi-asserted-by":"crossref","first-page":"420-U144","DOI":"10.1038\/ncb1849","article-title":"Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt\/PKB","volume":"11","author":"Lin","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2010.11.007_bb0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12253-009-9171-z","article-title":"The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma","volume":"15","author":"Lu","year":"2009","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.taap.2010.11.007_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K\u2013Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2010.11.007_bb0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10637-009-9269-x","article-title":"The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines","volume":"28","author":"Ma","year":"2010","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.taap.2010.11.007_bb0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.oraloncology.2008.07.011","article-title":"Dysregulated molecular networks in head and neck carcinogenesis","volume":"45","author":"Molinolo","year":"2009","journal-title":"Oral Oncol."},{"key":"10.1016\/j.taap.2010.11.007_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2010.11.007_bb0135","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2010.11.007_bb0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.taap.2006.12.003","article-title":"The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer","volume":"224","author":"Reagan-Shaw","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2010.11.007_bb0145","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr1533","article-title":"The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells","volume":"8","author":"Shapira","year":"2006","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.taap.2010.11.007_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2010.11.007_bb0155","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/1078-0432.CCR-08-0124","article-title":"A new fork for clinical application: targeting forkhead transcription factors in cancer","volume":"15","author":"Yang","year":"2009","journal-title":"Clin. Cancer Res."}],"updated-by":[{"DOI":"10.1016\/j.taap.2025.117397","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X10004394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X10004394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T09:49:02Z","timestamp":1559814542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X10004394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0041008X10004394"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2010.11.007","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}